FDA’s New Initiatives: Project Orbis and Real-Time Oncology Review

The U.S. Food and Drug Administration (FDA) recently announced two exciting and innovative initiatives from FDA's Oncology Center of Excellence: Project Orbis and Real-Time Oncology Review (RTOR) Pilot Program. Project Orbis On September 17, 2019 FDA announced Project Orbis, an initiative of the FDA Oncology Center of Excellence (OCE), to provide a framework for concurrent submission and review ...

Read More